Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC Enterobacteriaceae
Clinical trial NCT01543347 · WITHDRAWN
Trial details
- NCT number
- NCT01543347
- Sponsor
- Belpharma s.a.
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2012-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.